Marta Canel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Marta Canel has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Alan Serrels
Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh
2 shared publications - Kurt I. Anderson
The Beatson Institute for Cancer Research, Glasgow, UK
2 shared publications - Margaret C. Frame
Cancer Research UK Scotland Centre (Edinburgh), Institute of Genetics and Cancer, University of Edinburgh
2 shared publications Valerie G. Brunton
Edinburgh Cancer Research UK Centre; Institute of Genetics and Molecular Medicine; University of Edinburgh; Edinburgh, UK
2 shared publicationsAlan Serrels
Edinburgh Cancer Research Centre; Institute of Genetics and Molecular Medicine; University of Edinburgh; Edinburgh, UK
1 shared publication- Beverley Isherwood
Advanced Science and Technology Laboratory AstraZeneca R&D Charnwood Loughborough
1 shared publication
Latest Publications
- 1 July 2011
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 5 (4) , 360-365
Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement
Recent advances in confocal and multi-photon microscopy, together with fluorescent probe development, have enabled cancer biology studies to go beyond the culture dish and interrogate cancer-associated processes in the complex in vivo environment. Regulation of the tumor suppressor protein E-cadherin plays an important role in cancer development and progression and may contribute to the decision between ‘single cell’ and ‘collective invasion’ in vivo. Mounting evidence from in vitro and in vivo experiments places the two non-receptor protein tyrosine kinases Src and Focal Adhesion Kinase, at the heart of E-cadherin regulation, and the crosstalk between integrins and cadherins. Here we discuss recent insights, attained using high resolution fluorescent in vivo imaging, into the regulation of E-cadherin and collective invasion. We focus on the regulatory crosstalk between the Src/FAK signaling axis and E-cadherin in vivo.
- 1 July 2011
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 5 (4) , 360-365
Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement
Recent advances in confocal and multi-photon microscopy, together with fluorescent probe development, have enabled cancer biology studies to go beyond the culture dish and interrogate cancer-associated processes in the complex in vivo environment. Regulation of the tumor suppressor protein E-cadherin plays an important role in cancer development and progression and may contribute to the decision between ‘single cell’ and ‘collective invasion’ in vivo. Mounting evidence from in vitro and in vivo experiments places the two non-receptor protein tyrosine kinases Src and Focal Adhesion Kinase, at the heart of E-cadherin regulation, and the crosstalk between integrins and cadherins. Here we discuss recent insights, attained using high resolution fluorescent in vivo imaging, into the regulation of E-cadherin and collective invasion. We focus on the regulatory crosstalk between the Src/FAK signaling axis and E-cadherin in vivo.
- Open Access
- 4 April 2011
- Published by MDPI AG in Pharmaceutics
- Vol. 3 (2) , 141-170
Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery
Dynamic regulation of specific molecular processes and cellular phenotypes in live cell systems reveal unique insights into cell fate and drug pharmacology that are not gained from traditional fixed endpoint assays. Recent advances in microscopic imaging platform technology combined with the development of novel optical biosensors and sophisticated image analysis solutions have increased the scope of live cell imaging applications in drug discovery. We highlight recent literature examples where live cell imaging has uncovered novel insight into biological mechanism or drug mode-of-action. We survey distinct types of optical biosensors and associated analytical methods for monitoring molecular dynamics, in vitro and in vivo. We describe the recent expansion of live cell imaging into automated target validation and drug screening activities through the development of dedicated brightfield and fluorescence kinetic imaging platforms. We provide specific examples of how temporal profiling of phenotypic response signatures using such kinetic imaging platforms can increase the value of in vitro high-content screening. Finally, we offer a prospective view of how further application and development of live cell imaging technology and reagents can accelerate preclinical lead optimization cycles and enhance the in vitro to in vivo translation of drug candidates.
- 4 April 2011
- Published by MDPI AG in Pharmaceutics
- Vol. 3 (2) , 141-170
Open AccessLive Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery
Dynamic regulation of specific molecular processes and cellular phenotypes in live cell systems reveal unique insights into cell fate and drug pharmacology that are not gained from traditional fixed endpoint assays. Recent advances in microscopic imaging platform technology combined with the development of novel optical biosensors and sophisticated image analysis solutions have increased the scope of live cell imaging applications in drug discovery. We highlight recent literature examples where live cell imaging has uncovered novel insight into biological mechanism or drug mode-of-action. We survey distinct types of optical biosensors and associated analytical methods for monitoring molecular dynamics, in vitro and in vivo. We describe the recent expansion of live cell imaging into automated target validation and drug screening activities through the development of dedicated brightfield and fluorescence kinetic imaging platforms. We provide specific examples of how temporal profiling of phenotypic response signatures using such kinetic imaging platforms can increase the value of in vitro high-content screening. Finally, we offer a prospective view of how further application and development of live cell imaging technology and reagents can accelerate preclinical lead optimization cycles and enhance the in vitro to in vivo translation of drug candidates.
- Open Access
- 28 October 2010
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 4 (4) , 491-501
Use of photoactivation and photobleaching to monitor the dynamic regulation of E-cadherin at the plasma membrane
The dynamic control of E-cadherin is critical for establishing and maintaining cell-cell junctions in epithelial cells. The concentration of E-cadherin molecules at adherens junctions (AJs) is regu...
- 28 October 2010
- Published by Taylor & Francis in Cell Adhesion & Migration
- Vol. 4 (4) , 491-501
Open AccessUse of photoactivation and photobleaching to monitor the dynamic regulation of E-cadherin at the plasma membrane
The dynamic control of E-cadherin is critical for establishing and maintaining cell-cell junctions in epithelial cells. The concentration of E-cadherin molecules at adherens junctions (AJs) is regu...